Chlorothiazide : interactions médicamenteuses

Chlorothiazide (Diuril), diurétique thiazidique, présente 395 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 35 de niveau majeur, 311 de niveau modéré, 47 de niveau mineur et 2 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.

Interactions d'après la notice

Interactions majeures (35)

  • Acétazolamideinhibiteur de l'anhydrase carboniqueMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Acide étacryniquediurétique de l'anseMajeure

    CONTRAINDICATIONS All diuretics, including ethacrynic acid, are contraindicated in anuria. (notice Acide étacrynique, Contre-indications)

  • Amiloridediurétique épargneur de potassiumMajeure

    Hyperkalemia occurs commonly (about 10%) when amiloride is used without a kaliuretic diuretic. (notice Amiloride, Mise en garde encadrée)

  • Bicarbonate de sodiumantiacideMajeure

    Sodium bicarbonate injection is contraindicated in patients who are losing chloride by vomiting or from continuous gastrointestinal suction and in patients receiving diuretics known to produce a hypochloremic alkalosis. (notice Bicarbonate de sodium, Contre-indications)

  • Brinzolamideinhibiteur de l'anhydrase carboniqueMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Bumétanidediurétique de l'anseMajeure

    WARNING Bumetanide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. (notice Bumétanide, Mise en garde encadrée)

  • Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (notice Choriogonadotropine alfa, Mises en garde)

  • CiclosporineimmunosuppresseurMajeure

    Potassium-Sparing Diuretics Cyclosporine should not be used with potassium-sparing diuretics because hyperkalemia can occur. (notice Ciclosporine, Interactions médicamenteuses)

  • Citrate de potassiumsupplément de potassiumMajeure

    The following drug interactions may occur with potassium citrate: Potassium-sparing diuretics: concomitant administration should be avoided since the simultaneous administration of these agents can produce severe hyperkalemia (7.1) (notice Citrate de potassium, Interactions médicamenteuses)

  • ClozapineantipsychotiqueMajeure

    Use CLOZARIL cautiously in patients with cardiovascular or cerebrovascular disease or conditions predisposing to hypotension (e.g., dehydration, use of antihypertensive medications) [see Dosage and Administration ( 2.2 , 2.6 ), Warnings and Precautions ( 5.2 )]. (notice Clozapine, Mise en garde encadrée)

  • DiazoxideMajeure

    CONTRAINDICATIONS PROGLYCEM is contraindicated in patients with: Functional hypoglycemia Hypersensitivity to diazoxide, any of the excipients in PROGLYCEM, or other thiazides (notice Diazoxide, Contre-indications)

  • Diclofénamideinhibiteur de l'anhydrase carboniqueMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • DofétilideantiarythmiqueMajeure

    In the DIAMOND trials, 1252 patients were treated with dofetilide and diuretics concomitantly, of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and diuretics. (notice Dofétilide, Interactions médicamenteuses)

  • Dorzolamideinhibiteur de l'anhydrase carboniqueMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Dorzolamide et timololinhibiteur de l'anhydrase carboniqueMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Dropéridolantagoniste de la dopamineMajeure

    Droperidol should be administered with extreme caution to patients who may be at risk for development of prolonged QT syndrome (e.g., congestive heart failure, bradycardia, use of a diuretic, cardiac hypertrophy, hypokalemia, hypomagnesemia, or administration of other drugs known to increase the QT interval). (notice Dropéridol, Mise en garde encadrée)

  • Énalaprilateinhibiteur de l'enzyme de conversion (IEC)Majeure

    …sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include those with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. (notice Énalaprilate, Mises en garde)

  • Éplérénoneantagoniste de l'aldostéroneMajeure

    …• serum creatinine > 2.0 mg/dL in males or >1.8 mg/dL in females, • creatinine clearance < 50 mL/min, or • concomitant administration of potassium supplements or potassium-sparing diuretics (e.g., amiloride, spironolactone, or triamterene) [see Warnings and Precautions (5.1) , Adverse Reactions (6.2) , Drug Interactions (7) , and Clinical Pharmacology (12.3)… (notice Éplérénone, Contre-indications)

  • Eptifibatideantiagrégant plaquettaireMajeure

    …of active abnormal bleeding within the previous 30 days Severe hypertension (systolic blood pressure >200 mm Hg or diastolic blood pressure >110 mm Hg) not adequately controlled on antihypertensive therapy Major surgery within the preceding 6 weeks History of stroke within 30 days or any history of hemorrhagic stroke Current or planned administration of another… (notice Eptifibatide, Contre-indications)

  • Because the use of diuretics can accentuate the diminished intravascular volume, diuretics should be avoided except in the late phase of resolution as described below. (notice Follitropine, Mises en garde et précautions)

  • GentamicineaminosideMajeure

    The concurrent use of gentamicin with potent diuretics, such as ethacrynic acid or furosemide, should be avoided, since certain diuretics by themselves may cause ototoxicity. (notice Gentamicine, Mise en garde encadrée)

  • Avoid diuretics or laxatives in patients with diarrhea. (notice Irinotécan, Mises en garde et précautions)

  • Itraconazoleantifongique azoléMajeure

    Diuretics Eplerenone Contraindicated during and 2 weeks after TOLSURA treatment. (notice Itraconazole, Interactions médicamenteuses)

  • Méthazolamideinhibiteur de l'anhydrase carboniqueMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Métolazonediurétique thiazidiqueMajeure

    Other Antihypertensive Drugs When metolazone tablets, USP, are used with other antihypertensive drugs, particular care must be taken to avoid excessive reduction of blood pressure, especially during initial therapy. (notice Métolazone, Mises en garde)

  • MinoxidilvasodilatateurMajeure

    Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents. (notice Minoxidil, Mise en garde encadrée)

  • NéomycineaminosideMajeure

    The concurrent use of neomycin with potent diuretics such as ethacrynic acid or furosemide should be avoided, since certain diuretics by themselves may cause ototoxicity. (notice Néomycine, Mise en garde encadrée)

  • Quinaprilinhibiteur de l'enzyme de conversion (IEC)Majeure

    …sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include patients with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. (notice Quinapril, Mises en garde)

  • SulfadiazinesulfamideMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Sulfadiazine argentiquesulfamideMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • SulfasalazinesulfamideMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Tadalafilinhibiteur de la PDE5Majeure

    …coadministration of an alpha-blocker and CIALIS for the treatment of BPH has not been adequately studied, and due to the potential vasodilatory effects of combined use resulting in blood pressure lowering, the combination of CIALIS and alpha-blockers is not recommended for the treatment of BPH. [see Dosage and Administration ( 2.7 ), Drug Interactions ( 7.1 ),… (notice Tadalafil, Mises en garde et précautions)

  • Trioxyde d'arsenicmédicament allongeant l'intervalle QTMajeure

    The risk of torsade de pointes is related to the extent of QTc prolongation, concomitant administration of QTc prolonging drugs, a history of torsade de pointes, pre-existing QTc interval prolongation, congestive heart failure, administration of potassium-wasting diuretics, or other conditions that result in hypokalemia or hypomagnesemia. (notice Trioxyde d'arsenic, Mises en garde et précautions)

  • ZonisamideanticonvulsivantMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

Interactions modérées (311)

  • AcarboseantidiabétiqueModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • AcébutololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Acide méfénamiqueAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Acide zolédroniquebisphosphonateModérée

    Elderly patients and those receiving diuretic therapy are at increased risk of acute renal failure. (notice Acide zolédronique, Mises en garde et précautions)

  • AdrénalinesympathomimétiqueModérée

    …Precautions (5.6) and Adverse Reactions (6) ]. β-blockers, such as propranolol Cyclopropane or halogenated hydrocarbon anesthetics, such as halothane Antihistamines Thyroid hormones Diuretics Cardiac glycosides, such as digitalis glycosides Quinidine Drugs potentiating hypokalemic effects of epinephrine • Potassium depleting diuretics • Corticosteroids • Theophylline… (notice Adrénaline, Interactions médicamenteuses)

  • AlcoolAlcoolModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • AlfuzosinealphabloquantModérée

    Postural hypotension/syncope: Care should be taken in patients with symptomatic hypotension or who have had a hypotensive response to other medications or are concomitantly treated with antihypertensive medication or nitrates ( 5.1 ) (notice Alfuzosine, Mises en garde et précautions)

  • AliskirèneantihypertenseurModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Allopurinolinhibiteur de la xanthine oxydaseModérée

    Hypersensitivity reactions to allopurinol tablets may be increased in patients with decreased kidney function receiving thiazide diuretics and allopurinol tablets concurrently. (notice Allopurinol, Mises en garde et précautions)

  • Alogliptineinhibiteur de la DPP-4Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alogliptine et metformineinhibiteur de la DPP-4Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Amfépramonestimulant du SNCModérée

    The pressor effects of diethylpropion and those of other drugs may be additive when the drugs are used concomitantly; conversely, diethylpropion may interfere with antihypertensive drugs (i.e., guanethidine, a-methyldopa). (notice Amfépramone, Interactions médicamenteuses)

  • AmikacineaminosideModérée

    Ethacrynic Acid, Furosemide, Urea, or Mannitol Some diuretics can enhance aminoglycoside toxicity by altering aminoglycoside concentrations in serum and tissue. (notice Amikacine, Interactions médicamenteuses)

  • AmiodaroneantiarythmiqueModérée

    Give special attention to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or in patients receiving concomitant diuretics and laxatives. (notice Amiodarone, Mises en garde et précautions)

  • Amlodipineinhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Amlodipine et atorvastatineinhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Amlodipine et bénazéprilinhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Amlodipine et olmésartaninhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Amlodipine et valsartaninhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Arformotérolagoniste bêta-adrénergiqueModérée

    Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes. (notice Arformotérol, Interactions médicamenteuses)

  • AripiprazoleantipsychotiqueModérée

    Antihypertensive Drugs Due to its alpha-adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents. (notice Aripiprazole, Interactions médicamenteuses)

  • Armodafinilstimulant du SNCModérée

    There was also a slightly greater proportion of patients on NUVIGIL requiring new or increased use of antihypertensive medications (2.9%) compared to patients on placebo (1.8%). (notice Armodafinil, Mises en garde et précautions)

  • AsénapineantipsychotiqueModérée

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medications, patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), and patients… (notice Asénapine, Mises en garde et précautions)

  • AspirineAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Aspirine et dipyridamoleantiagrégant plaquettaireModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • AténololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Aténolol et chlortalidonebêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Atomoxétineinhibiteur de la recapture de la noradrénalineModérée

    Antihypertensive Drugs Prevention or Management Increase the frequency of monitoring blood pressure and adjust atomoxetine oral solution dosage as clinically appropriate. (notice Atomoxétine, Interactions médicamenteuses)

  • Avanafilinhibiteur de la PDE5Modérée

    • Use of avanafil with alpha-blockers, other antihypertensives, or substantial amounts of alcohol (greater than 3 units) may lead to hypotension ( 2.3 , 5.6 , 5.7 ) (notice Avanafil, Mises en garde et précautions)

  • Azilsartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • BaclofènemyorelaxantModérée

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • Belladone et opiumopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Bénazéprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Bénazépril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Benzfétaminestimulant du SNCModérée

    Amphetamines may decrease the hypotensive effect of antihypertensives. (notice Benzfétamine, Interactions médicamenteuses)

  • BétaxololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Bexagliflozineinhibiteur du SGLT2Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • BisoprololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Bisoprolol et hydrochlorothiazidebêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • BortézomibModérée

    Hypotension: Use caution when treating patients taking antihypertensives, with a history of syncope, or with dehydration. (notice Bortézomib, Mises en garde et précautions)

  • BrexpiprazoleantipsychotiqueModérée

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medication), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (notice Brexpiprazole, Mises en garde et précautions)

  • Brimonidineagoniste alpha-adrénergiqueModérée

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (notice Brimonidine, Interactions médicamenteuses)

  • Brimonidine et timololagoniste alpha-adrénergiqueModérée

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate/timolol maleate ophthalmic solution may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate/timolol maleate ophthalmic solution is advised. (notice Brimonidine et timolol, Interactions médicamenteuses)

  • Bromocriptineagoniste de la dopamineModérée

    Use caution in patients taking antihypertensive medications. (notice Bromocriptine, Mises en garde et précautions)

  • Central Nervous System (CNS) depressants Antihistamines have additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, antianxiety agents, etc.). Antihypertensive drugs Sympathomimetic may reduce the effects of antihypertensive drugs. (notice Bromphéniramine, pseudoéphédrine et dextrométhorphane, Interactions médicamenteuses)

  • Budésonide et formotérolcorticoïdeModérée

    Diuretics: Use with caution. (notice Budésonide et formotérol, Interactions médicamenteuses)

  • BuprénorphineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Butalbital et paracétamolbarbituriqueModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • ButorphanolopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Calcitriolanalogue de la vitamine DModérée

    Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (notice Calcitriol, Interactions médicamenteuses)

  • Canagliflozineinhibiteur du SGLT2Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Candésartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Candésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Captoprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • CarbamazépineanticonvulsivantModérée

    Elderly patients and patients treated with diuretics are at greater risk of developing hyponatremia. (notice Carbamazépine, Mises en garde et précautions)

  • CarbidopaModérée

    Symptomatic postural hypotension has occurred when carbidopa, given with levodopa or carbidopa-levodopa combination products, was added to the treatment of a patient receiving antihypertensive drugs. (notice Carbidopa, Interactions médicamenteuses)

  • Carbidopa et lévodopamédicament dopaminergiqueModérée

    Antihypertensive drugs: May cause symptomatic postural hypotension. (notice Carbidopa et lévodopa, Interactions médicamenteuses)

  • Carbidopa, lévodopa et entacaponemédicament dopaminergiqueModérée

    Antihypertensive Agents Symptomatic postural hypotension has occurred when carbidopa/levodopa was added to the treatment of patients receiving antihypertensive drugs. (notice Carbidopa, lévodopa et entacapone, Interactions médicamenteuses)

  • CariprazineantipsychotiqueModérée

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (notice Cariprazine, Mises en garde et précautions)

  • CarisoprodolmyorelaxantModérée

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • CarvédilolbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • CéfépimecéphalosporineModérée

    Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (notice Céfépime, Interactions médicamenteuses)

  • CeftazidimecéphalosporineModérée

    Drug Interactions Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibacterial drugs or potent diuretics such as furosemide. (notice Ceftazidime, Interactions médicamenteuses)

  • CélécoxibAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • ChlorpromazineantipsychotiqueModérée

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (notice Chlorpromazine, Précautions)

  • Chlortalidonediurétique thiazidiqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Drugs That Increase the Risk of Hypercalcemia Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D). (notice Chlorure de calcium, Interactions médicamenteuses)

  • ChlorzoxazonemyorelaxantModérée

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • CitalopramISRSModérée

    Elderly patients, patients taking diuretics, and those who are volume depleted may be at greater risk for developing hyponatremia with SSRIs [see Use in Specific Populations ( 8.5 )] . (notice Citalopram, Mises en garde et précautions)

  • ClofarabineantimétaboliteModérée

    Consider use of diuretics and/or albumin. (notice Clofarabine, Mises en garde et précautions)

  • Clonidineagoniste alpha-adrénergiqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • CodéineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Colestipolchélateur des acides biliairesModérée

    Studies in humans show that the absorption of chlorothiazide as reflected in urinary excretion is markedly decreased even when administered one hour before colestipol hydrochloride. (notice Colestipol, Interactions médicamenteuses)

  • Colestyraminechélateur des acides biliairesModérée

    Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (notice Colestyramine, Interactions médicamenteuses)

  • CyclobenzaprinemyorelaxantModérée

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • CyclophosphamideimmunosuppresseurModérée

    …inhibitors: ACE inhibitors can cause leukopenia. ● Natalizumab ● Paclitaxel: Increased hematotoxicity has been reported when cyclophosphamide was administered after paclitaxel infusion. ● Thiazide diuretics ● Zidovudine Increased cardiotoxicity ● Anthracyclines ● Cytarabine ● Pentostatin ● Radiation therapy of the cardiac region ● Trastuzumab Increased pulmonary toxicity… (notice Cyclophosphamide, Interactions médicamenteuses)

  • Increase the dose of diuretics as needed [see Adverse Reactions (6) ] . (notice Cyclosilicate de zirconium sodique, Mises en garde et précautions)

  • DantrolènemyorelaxantModérée

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • Dapagliflozineinhibiteur du SGLT2Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Dapagliflozine et metformineinhibiteur du SGLT2Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Désipramineantidépresseur tricycliqueModérée

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with NORPRAMIN. (notice Désipramine, Mises en garde)

  • DesmopressineModérée

    …Hyponatremia Concomitant administration of DESMODA with other drugs that may increase the risk of water intoxication with hyponatremia, (e.g., tricyclic antidepressants, selective serotonin re-uptake inhibitors, chlorpromazine, opiate analgesics, thiazide diuretics, NSAIDs, lamotrigine, sulfonylureas, particularly chlorpropamide, oxybutynin and carbamazepine). (notice Desmopressine, Interactions médicamenteuses)

  • DesvenlafaxineIRSNaModérée

    Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk [see Use in Specific Populations (8.5) and Clinical Pharmacology (12.3) ] . (notice Desvenlafaxine, Mises en garde et précautions)

  • Dexlansoprazoleinhibiteur de la pompe à protons (IPP)Modérée

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (notice Dexlansoprazole, Mises en garde et précautions)

  • Dexméthylphénidatestimulant du SNCModérée

    • Antihypertensive Drugs: Monitor blood pressure. (notice Dexméthylphénidate, Interactions médicamenteuses)

  • DiclofénacAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • DiflunisalAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Digoxineglycoside digitaliqueModérée

    Serum potassium levels should be carefully monitored when digoxin is given to patients at high risk of hypokalemia ( e.g. , those receiving diuretics, corticosteroids, or other drugs that commonly lead to potassium loss; those with gastrointestinal losses through diarrhea, vomiting, or nasogastric suction; or those with potassium-losing endocrinopathies or nephropathies). (notice Digoxine, Mises en garde et précautions)

  • Diltiazeminhibiteur calciqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • DoxazosinealphabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Doxercalciférolanalogue de la vitamine DModérée

    Risk may be increased when used concomitantly with high dose calcium preparations, thiazide diuretics, or vitamin D compounds. (notice Doxercalciférol, Mises en garde et précautions)

  • Drospirénone et éthinylestradiolcontraceptif oralModérée

    Medications that may increase serum potassium concentration include ACE inhibitors, angiotensin-II receptor antagonists, potassium-sparing diuretics, potassium supplementation, heparin, aldosterone antagonists, and NSAIDS. (notice Drospirénone et éthinylestradiol, Mises en garde et précautions)

  • Dulaglutideagoniste du récepteur du GLP-1Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • DuloxétineIRSNaModérée

    The risk of BP decreases may be greater in patients taking concomitant medications that induce orthostatic hypotension (such as antihypertensives) or are potent CYP1A2 inhibitors [see Drug Interactions ( 7.1 )] and in patients taking duloxetine delayed-release capsules at doses above 60 mg daily. (notice Duloxétine, Mises en garde et précautions)

  • ÉluxadolineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Empagliflozineinhibiteur du SGLT2Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Empagliflozine et metformineinhibiteur du SGLT2Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Énalaprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Énalapril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Following initiation and titration of Epogen, approximately 25% of patients on dialysis required initiation of or increases in antihypertensive therapy; hypertensive encephalopathy and seizures have been reported in patients with CKD receiving Epogen. (notice Époétine alfa, Mises en garde et précautions)

  • Époprosténolanalogue de prostaglandineModérée

    Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. (notice Époprosténol, Interactions médicamenteuses)

  • EscitalopramISRSModérée

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk. (notice Escitalopram, Mises en garde et précautions)

  • EsmololbêtabloquantModérée

    Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension. (notice Esmolol, Interactions médicamenteuses)

  • Ésoméprazoleinhibiteur de la pompe à protons (IPP)Modérée

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (notice Ésoméprazole, Mises en garde et précautions)

  • ÉtodolacAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Exénatideagoniste du récepteur du GLP-1Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Félodipineinhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • FénoprofèneAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • FentanylopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Fluconazoleantifongique azoléModérée

    An effect of this magnitude should not necessitate a change in the fluconazole dose regimen in subjects receiving concomitant diuretics. (notice Fluconazole, Interactions médicamenteuses)

  • FludrocortisonecorticoïdeModérée

    Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (notice Fludrocortisone, Interactions médicamenteuses)

  • FluoxétineISRSModérée

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk [see Use in Specific Populations ( 8.5 )] . (notice Fluoxétine, Mises en garde et précautions)

  • FlurbiprofèneAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Fluticasone et salmétérolcorticoïdeModérée

    Diuretics: Use with caution. (notice Fluticasone et salmétérol, Interactions médicamenteuses)

  • FluvoxamineISRSModérée

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk. (notice Fluvoxamine, Mises en garde et précautions)

  • Formotérolagoniste bêta-adrénergiqueModérée

    • Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes. (notice Formotérol, Interactions médicamenteuses)

  • FoscarnetantiviralModérée

    When diuretics are indicated, thiazides are recommended over loop diuretics because the latter inhibit renal tubular secretion, and may impair elimination of FOSCAVIR, potentially leading to toxicity. (notice Foscarnet, Interactions médicamenteuses)

  • Fosinoprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Fosinopril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Furosémidediurétique de l'anseModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Glibenclamidesulfamide hypoglycémiantModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Glibenclamide et metforminesulfamide hypoglycémiantModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Glimépiridesulfamide hypoglycémiantModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Glipizidesulfamide hypoglycémiantModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Glipizide et metforminesulfamide hypoglycémiantModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Guanfacineagoniste alpha-adrénergiqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • HalopéridolantipsychotiqueModérée

    Caution is advised when haloperidol decanoate is used in combination with drugs known to cause electrolyte imbalance (e.g., diuretics or corticosteroids) because hypokalemia, hypomagnesemia, and hypocalcemia are risk factors for QT prolongation. (notice Halopéridol, Interactions médicamenteuses)

  • HydralazinevasodilatateurModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Hydrochlorothiazidediurétique thiazidiqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • HydrocodoneopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • HydromorphoneopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • IbuprofèneAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • IlopéridoneantipsychotiqueModérée

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (notice Ilopéridone, Mises en garde et précautions)

  • Imipramineantidépresseur tricycliqueModérée

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with imipramine hydrochloride tablets. (notice Imipramine, Mises en garde)

  • Indapamidediurétique thiazidiqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • IndométacineAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Insuline asparteinsulineModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Insuline dégludecinsulineModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Insuline détémirinsulineModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Insuline glargineinsulineModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Insuline lisproinsulineModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Insuline rapide (humaine)insulineModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Concurrent use with potassium-containing medications, potassium-sparing diuretics and angiotensin-converting enzyme inhibitors (ACE inhibitors) may result in hyperkalemia and cardiac arrhythmias or cardiac arrest. (notice Iodure de potassium, Interactions médicamenteuses)

  • Ipratropium et salbutamolanticholinergiqueModérée

    Diuretics The electrocardiogram (ECG) changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by β-agonists, especially when the recommended dose of the β-agonist is exceeded. (notice Ipratropium et salbutamol, Interactions médicamenteuses)

  • Irbésartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Irbésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Isradipineinhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Kétoconazoleantifongique azoléModérée

    Diuretics eplerenone The potential increase in plasma concentrations of eplerenone when coadministered with ketoconazole tablets may increase the risk of hyperkalemia and hypotension. (notice Kétoconazole, Interactions médicamenteuses)

  • KétoprofèneAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • KétorolacAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • LabétalolbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Lansoprazoleinhibiteur de la pompe à protons (IPP)Modérée

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (notice Lansoprazole, Mises en garde et précautions)

  • LévomilnacipranIRSNaModérée

    Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk. (notice Lévomilnacipran, Mises en garde et précautions)

  • LévorphanolopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Lévosalbutamolagoniste bêta-adrénergiqueModérée

    Diuretics The ECG changes or hypokalemia that may result from the administration of non-potassium-sparing diuretics (such as loop and thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded. (notice Lévosalbutamol, Interactions médicamenteuses)

  • Linagliptineinhibiteur de la DPP-4Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Linagliptine et metformineinhibiteur de la DPP-4Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • LinézolideantibiotiqueModérée

    Monitor serum sodium levels regularly in the elderly, in patients taking diuretics, and in other patients at risk of hyponatremia and/or SIADH while taking Linezolid injection. (notice Linézolide, Mises en garde et précautions)

  • Liraglutideagoniste du récepteur du GLP-1Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Lisinoprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Lisinopril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Lithiummédicament sérotoninergiqueModérée

    Lithium generally should not be given with diuretics (see PRECAUTIONS , Drug Interactions ). (notice Chlorothiazide, Mises en garde)

  • Lofexidineagoniste alpha-adrénergiqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Losartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Losartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • LumatépéroneantipsychotiqueModérée

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive drugs), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and patients… (notice Lumatépérone, Mises en garde et précautions)

  • LurasidoneantipsychotiqueModérée

    Patients at increased risk of these adverse reactions or at increased risk of developing complications from hypotension include those with dehydration, hypovolemia, treatment with antihypertensive medication, history of cardiovascular disease (e.g., heart failure, myocardial infarction, ischemia, or conduction abnormalities), history of cerebrovascular disease,… (notice Lurasidone, Mises en garde et précautions)

  • MécamylamineantihypertenseurModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • MéloxicamAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • MétaxalonemyorelaxantModérée

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • MetforminebiguanideModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • MéthadoneopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • MéthocarbamolmyorelaxantModérée

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • MéthohexitalbarbituriqueModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • MéthyldopaantihypertenseurModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Méthylphénidatestimulant du SNCModérée

    Antihypertensive Drugs: Monitor blood pressure. (notice Méthylphénidate, Interactions médicamenteuses)

  • MétoprololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • MiglitolantidiabétiqueModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • MilnacipranIRSNaModérée

    Also, patients taking diuretics or who are otherwise volume-depleted may be at greater risk [see Geriatric Use ( 8.5 )] . (notice Milnacipran, Mises en garde et précautions)

  • MirtazapineantidépresseurModérée

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia [see Use in Specific Populations (8.5) ] . (notice Mirtazapine, Mises en garde et précautions)

  • Modafinilstimulant du SNCModérée

    However, a retrospective analysis of the use of antihypertensive medication in these studies showed that a greater proportion of patients on PROVIGIL required new or increased use of antihypertensive medications (2.4%) compared to patients on placebo (0.7%). (notice Modafinil, Mises en garde et précautions)

  • Moexiprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • MorphineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • NabumétoneAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • NadololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • NalbuphineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • NaproxèneAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • NatéglinideglinideModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • NébivololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • NiacineModérée

    Antihypertensive Therapy Niacin may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension. (notice Niacine, Interactions médicamenteuses)

  • Nicardipineinhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Nifédipineinhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Nimodipineinhibiteur calcique dihydropyridiniqueModérée

    Blood Pressure Lowering Drugs Nimodipine may increase the blood pressure lowering effect of concomitantly administered anti-hypertensives such as diuretics, beta-blockers, ACE inhibitors, angiotensin receptor blockers, other calcium channel blockers, α-adrenergic blockers, PDE5 inhibitors, and α-methyldopa. (notice Nimodipine, Interactions médicamenteuses)

  • Nisoldipineinhibiteur calcique dihydropyridiniqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Nitroprussiate de sodiumvasodilatateurModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • OlanzapineantipsychotiqueModérée

    …of myocardial infarction or ischemia, heart failure, or conduction abnormalities), cerebrovascular disease, and conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications) where the occurrence of syncope, or hypotension and/or bradycardia might put the patient at increased medical risk. (notice Olanzapine, Mises en garde et précautions)

  • Olanzapine et fluoxétineantipsychotiqueModérée

    …and fluoxetine capsules should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemia, heart failure, or conduction abnormalities), cerebrovascular disease, or conditions that would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (notice Olanzapine et fluoxétine, Mises en garde et précautions)

  • OlicéridineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Olmésartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Olmésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Olmésartan, amlodipine et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Oméprazoleinhibiteur de la pompe à protons (IPP)Modérée

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions ( 6.2 )] . (notice Oméprazole, Mises en garde et précautions)

  • Oméprazole et bicarbonate de sodiuminhibiteur de la pompe à protons (IPP)Modérée

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions ( 6.2 )] . (notice Oméprazole et bicarbonate de sodium, Mises en garde et précautions)

  • OrphénadrinemyorelaxantModérée

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (notice Chlorothiazide, Interactions médicamenteuses)

  • OxaprozineAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • OxycodoneopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Oxycodone et paracétamolopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • OxymorphoneopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • PalipéridoneantipsychotiqueModérée

    Use ERZOFRI with caution in patients with known cardiovascular disease (e.g., heart failure, history of myocardial infarction or ischemia, conduction abnormalities), cerebrovascular disease, or conditions that predispose the patient to hypotension (e.g., dehydration, hypovolemia, and treatment with antihypertensive medications). (notice Palipéridone, Mises en garde et précautions)

  • Pantoprazoleinhibiteur de la pompe à protons (IPP)Modérée

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ]. (notice Pantoprazole, Mises en garde et précautions)

  • Paracétamol et codéineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Paricalcitolanalogue de la vitamine DModérée

    The risk may be increased when Paricalcitol Injection is used concomitantly with high dose calcium preparations, thiazide diuretics, or vitamin D compounds. (notice Paricalcitol, Mises en garde et précautions)

  • ParoxétineISRSModérée

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SNRIs and SSRIs. [see Use in Specific Populations ( 8.5 )]. (notice Paroxétine, Mises en garde et précautions)

  • PazopanibModérée

    Monitor blood pressure as clinically indicated and initiate and adjust antihypertensive therapy as appropriate. (notice Pazopanib, Mises en garde et précautions)

  • Pentazocine et naloxoneopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • PentoxifyllineméthylxanthineModérée

    Small decreases in blood pressure have been observed in some patients treated with pentoxifylline extended-release tablets; periodic systemic blood pressure monitoring is recommended for patients receiving concomitant antihypertensive therapy. (notice Pentoxifylline, Interactions médicamenteuses)

  • Périndoprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • PéthidineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • PhénelzineIMAOModérée

    …hydrochloride desipramine hydrochloride imipramine hydrochloride doxepin carbamazepine cyclobenzaprine HCl amoxapine maprotiline HCl trimipramine maleate protriptyline HCl mirtazapine Phenelzine sulfate should be used with caution in combination with antihypertensive drugs, including thiazide diuretics and β-blockers, since exaggerated hypotensive effects may result. (notice Phénelzine, Mises en garde)

  • PhénobarbitalbarbituriqueModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • PhénoxybenzaminealphabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Phentermine et topiramatestimulant du SNCModérée

    In addition, when phentermine and topiramate extended-release capsules are used in conjunction with nonpotassium sparing diuretics this may further potentiate potassium-wasting. (notice Phentermine et topiramate, Mises en garde et précautions)

  • PindololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • PioglitazonethiazolidinedioneModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Pioglitazone et glimépiridethiazolidinedioneModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Pioglitazone et metforminethiazolidinedioneModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • PiroxicamAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • PrazosinealphabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • PrimidoneanticonvulsivantModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • ProchlorpérazineantipsychotiqueModérée

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (notice Prochlorpérazine, Précautions)

  • Prométhazine et codéineopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • PropranololbêtabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • QuétiapineantipsychotiqueModérée

    Quetiapine should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), cerebrovascular disease, or conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (notice Quétiapine, Mises en garde et précautions)

  • Quinapril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • QuinidineantiarythmiqueModérée

    Drugs that alkalinize the urine ( carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics ) reduce renal elimination of quinidine. (notice Quinidine, Interactions médicamenteuses)

  • Rabéprazoleinhibiteur de la pompe à protons (IPP)Modérée

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ]. (notice Rabéprazole, Mises en garde et précautions)

  • Ramiprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • RémifentanilopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • RépaglinideglinideModérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • RiociguatvasodilatateurModérée

    Consider the potential for symptomatic hypotension or ischemia in patients with hypovolemia, severe left ventricular outflow obstruction, resting hypotension, autonomic dysfunction, or concomitant treatment with antihypertensives or strong CYP and P-gp/BCRP inhibitors [see Drug Interactions (7.2) and Clinical Pharmacology (12.3) ] . (notice Riociguat, Mises en garde et précautions)

  • RispéridoneantipsychotiqueModérée

    Clinically significant hypotension has been observed with concomitant use of oral RISPERDAL and antihypertensive medication. (notice Rispéridone, Mises en garde et précautions)

  • Sacubitril et valsartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Salbutamolagoniste bêta-adrénergiqueModérée

    Diuretics: Use with caution. (notice Salbutamol, Interactions médicamenteuses)

  • Salmétérolagoniste bêta-adrénergiqueModérée

    • Diuretics: Use with caution. (notice Salmétérol, Interactions médicamenteuses)

  • SalsalateAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Saxagliptineinhibiteur de la DPP-4Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Saxagliptine et metformineinhibiteur de la DPP-4Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Sémaglutideagoniste du récepteur du GLP-1Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • SertralineISRSModérée

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs [see Use in Specific Populations ( 8.5 )] . (notice Sertraline, Mises en garde et précautions)

  • Sildénafilinhibiteur de la PDE5Modérée

    Caution is advised when SILDENAFIL ORAL FILM is co-administered with alpha-blockers or antihypertensives. (notice Sildénafil, Mises en garde et précautions)

  • SilodosinealphabloquantModérée

    However, patients in the Phase 3 clinical studies taking concomitant antihypertensive medications with silodosin capsules did not experience a significant increase in the incidence of syncope, dizziness, or orthostasis. (notice Silodosine, Mises en garde et précautions)

  • Sitagliptineinhibiteur de la DPP-4Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • Sitagliptine et metformineinhibiteur de la DPP-4Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • SorafénibModérée

    Consider temporary or permanent discontinuation for severe or persistent hypertension despite antihypertensive therapy. (notice Sorafénib, Mises en garde et précautions)

  • SotalolbêtabloquantModérée

    Special attention should be given to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or patients receiving concomitant diuretic drugs. (notice Sotalol, Mises en garde et précautions)

  • Spironolactoneantagoniste de l'aldostéroneModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Spironolactone et hydrochlorothiazideantagoniste de l'aldostéroneModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • SulindacAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • SunitinibModérée

    Initiate and/or adjust antihypertensive therapy as appropriate. (notice Sunitinib, Mises en garde et précautions)

  • Suxaméthoniumbloquant neuromusculaireModérée

    Prolonged Neuromuscular Block in Patients with Hypokalemia or Hypocalcemia Neuromuscular blockade may be prolonged in patients with hypokalemia (e.g., after severe vomiting, diarrhea, digitalisation and diuretic therapy) or hypocalcemia (e.g., after massive transfusions). (notice Suxaméthonium, Mises en garde et précautions)

  • TacrolimusimmunosuppresseurModérée

    • Hypertension: May require antihypertensive therapy; monitor relevant drug interactions. (notice Tacrolimus, Mises en garde et précautions)

  • TapentadolopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Telmisartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Telmisartan et amlodipineantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Telmisartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • TérazosinealphabloquantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Terbutalineagoniste bêta-adrénergiqueModérée

    Diuretics The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded. (notice Terbutaline, Précautions)

  • TestostéroneandrogèneModérée

    In patients with hypertension on antihypertensive therapy, TLANDO increased the mean systolic/diastolic BP by 4.8/1.6 mm Hg from baseline. [see Adverse Reactions ( 6.1 )] . (notice Testostérone, Mises en garde et précautions)

  • Tirzépatideagoniste du récepteur du GLP-1Modérée

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (notice Chlorothiazide, Interactions médicamenteuses)

  • TizanidinemyorelaxantModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • TobramycineaminosideModérée

    Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. (notice Tobramycine, Interactions médicamenteuses)

  • TolmétineAINSModérée

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (notice Chlorothiazide, Interactions médicamenteuses)

  • TolvaptanModérée

    Co-administration of diuretics also increases the risk of too rapid correction of serum sodium and such patients should undergo close monitoring of serum sodium. (notice Tolvaptan, Mises en garde et précautions)

  • Torasémidediurétique de l'anseModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Torémifènemodulateur sélectif des récepteurs aux estrogènesModérée

    Drugs that decrease renal calcium excretion, e.g., thiazide diuretics, may increase the risk of hypercalcemia in patients receiving FARESTON. (notice Torémifène, Interactions médicamenteuses)

  • TramadolopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Tramadol et paracétamolopioïdeModérée

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (notice Chlorothiazide, Interactions médicamenteuses)

  • Trandolaprilinhibiteur de l'enzyme de conversion (IEC)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • TrazodoneantidépresseurModérée

    Concomitant use with an antihypertensive may require a reduction in the dose of the antihypertensive drug. (notice Trazodone, Mises en garde et précautions)

  • Triamtérènediurétique épargneur de potassiumModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Triamtérène et hydrochlorothiazidediurétique épargneur de potassiumModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • TrifluopérazineantipsychotiqueModérée

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (notice Trifluopérazine, Précautions)

  • Trinitrinedérivé nitréModérée

    Antihypertensives: Possible additive hypotensive effects. (notice Trinitrine, Interactions médicamenteuses)

  • Uméclidinium et vilantérolanticholinergiqueModérée

    • Diuretics: Use with caution. (notice Uméclidinium et vilantérol, Interactions médicamenteuses)

  • Valsartanantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Valsartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • Vardénafilinhibiteur de la PDE5Modérée

    Vardenafil hydrochloride tablets can potentiate the hypotensive effects of nitrates, alpha- blockers, and antihypertensives. (notice Vardénafil, Interactions médicamenteuses)

  • VenlafaxineIRSNaModérée

    Also, patients taking diuretics or who are otherwise volume-depleted may be at greater risk [see Use in Specific Populations ( 8.5 )] . (notice Venlafaxine, Mises en garde et précautions)

  • Vérapamilinhibiteur calciqueModérée

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (notice Chlorothiazide, Mises en garde)

  • VilazodoneISRSModérée

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs and SNRIs [see Use in Specific Populations ( 8.5 )] . (notice Vilazodone, Mises en garde et précautions)

  • Vitamine DVitamines et minérauxModérée

    Les diurétiques thiazidiques réduisent l'excrétion du calcium ; associés à des compléments de vitamine D et de calcium, ils peuvent entraîner une hypercalcémie, en particulier chez les personnes âgées. (NIH Office of Dietary Supplements, Vitamin D)

  • VortioxétineantidépresseurModérée

    Also, patients taking diuretics or who are otherwise volume-depleted can be at greater risk. (notice Vortioxétine, Mises en garde et précautions)

  • ZiprasidoneantipsychotiqueModérée

    Hypokalemia may result from diuretic therapy, diarrhea, and other causes. (notice Ziprasidone, Mises en garde et précautions)

Mentions mineures (47)

  • Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (notice Ambrisentan, Mises en garde et précautions)

  • Azélastine et fluticasoneantihistaminiqueMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • BéclométasonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • BétaméthasonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • Bosentaninducteur du CYP3A4Mineure

    Patients required intervention with a diuretic, fluid management, or hospitalization for decompensating heart failure. (notice Bosentan, Mises en garde et précautions)

  • BudésonidecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • CalciumVitamines et minérauxMineure

    Les diurétiques thiazidiques réduisent l'excrétion du calcium ; un apport élevé en calcium peut donc augmenter le taux de calcium dans le sang. (NIH Office of Dietary Supplements, Calcium)

  • CiclésonidecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • ClobétasolcorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • Acthar Gel may accentuate the electrolyte loss associated with diuretic therapy. (notice Corticotropine, Interactions médicamenteuses)

  • DasatinibMineure

    Fluid retention events were typically managed by supportive care measures that may include diuretics or short courses of steroids. (notice Dasatinib, Mises en garde et précautions)

  • DéflazacortcorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • Désogestrel et éthinylestradiolcontraceptif oralMineure

    If other contraceptive methods are not suitable, hormonal contraceptive therapy may continue combined with antihypertensive therapy. (notice Désogestrel et éthinylestradiol, Mises en garde)

  • DésonidecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • DexaméthasonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • Dexamfétaminestimulant du SNCMineure

    Examples of alkalinizing agents include gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) and urinary alkalinizing agents (e.g. acetazolamide, some thiazides). (notice Dexamfétamine, Interactions médicamenteuses)

  • DocétaxelMineure

    Patients developing peripheral edema may be treated with standard measures, e.g., salt restriction, oral diuretic(s). (notice Docétaxel, Mises en garde et précautions)

  • DronédaroneantiarythmiqueMineure

    Hypokalemia and Hypomagnesemia with Potassium-Depleting Diuretics Hypokalemia or hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. (notice Dronédarone, Mises en garde et précautions)

  • ÉphédrinesympathomimétiqueMineure

    Examples: α-adrenergic antagonists, β-adrenergic receptor antagonists, reserpine, quinidine, mephentermine Other Drug Interactions G u anethidine C linical Impact: Ephedrine may inhibit the neuron blockage produced by guanethidine, resulting in loss of antihypertensive effectiveness. (notice Éphédrine, Interactions médicamenteuses)

  • In addition to discontinuation of the drug, diuretic therapy may be required. (notice Estrogènes estérifiés et méthyltestostérone, Mises en garde)

  • Finastérideinhibiteur de la 5-alpha-réductaseMineure

    …clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives… (notice Finastéride, Interactions médicamenteuses)

  • FlécaïnideantiarythmiqueMineure

    Flecainide acetate has been used in a large number of patients receiving diuretics without apparent interaction. (notice Flécaïnide, Interactions médicamenteuses)

  • FlunisolidecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • FluocinonidecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • FluticasonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • Drugs that may cause hypercalcemia: Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. (notice Gluconate de calcium, Interactions médicamenteuses)

  • HalobétasolcorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • HydrocortisonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • IcatibantMineure

    ACE Inhibitors FIRAZYR is a bradykinin B2 receptor antagonist and thereby has the potential to have a pharmacodynamic interaction with ACE inhibitors where FIRAZYR may attenuate the antihypertensive effect of ACE inhibitors. (notice Icatibant, Interactions médicamenteuses)

  • Imatinibinhibiteur du CYP3A4Mineure

    Weigh patients regularly and manage unexpected rapid weight gain by drug interruption and diuretics. (notice Imatinib, Mises en garde et précautions)

  • MacitentanMineure

    Postmarketing cases of edema and fluid retention occurring within weeks of starting OPSUMIT, some requiring intervention with a diuretic or hospitalization for decompensated heart failure, have been reported [see Adverse Reactions (6.2) ] . (notice Macitentan, Mises en garde et précautions)

  • MagnésiumVitamines et minérauxMineure

    L'utilisation à long terme des diurétiques de l'anse et des diurétiques thiazidiques augmente la perte de magnésium dans les urines. (NIH Office of Dietary Supplements, Magnesium)

  • MéthylprednisolonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • MéthyltestostéroneandrogèneMineure

    In addition to discontinuation of the drug, diuretic therapy may be required. (notice Méthyltestostérone, Mises en garde)

  • MexilétineantiarythmiqueMineure

    In a large compassionate use program mexiletine has been used concurrently with commonly employed antianginal, antihypertensive, and anticoagulant drugs without observed interactions. (notice Mexilétine, Interactions médicamenteuses)

  • MométasonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • Nortriptylineantidépresseur tricycliqueMineure

    The antihypertensive action of guanethidine and similar agents may be blocked. (notice Nortriptyline, Mises en garde)

  • Olopatadine et mométasoneantihistaminiqueMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • Pénicilline Gantibiotique de la famille des pénicillinesMineure

    These drugs include: aspirin, phenylbutazone, sulfonamides, indomethacin, thiazide diuretics, furosemide and ethacrynic acid. (notice Pénicilline G, Interactions médicamenteuses)

  • Pipéracilline et tazobactamantibiotique de la famille des pénicillinesMineure

    Periodic electrolyte determinations should be performed in patients with low potassium reserves, and the possibility of hypokalemia should be kept in mind with patients who have potentially low potassium reserves and who are receiving cytotoxic therapy or diuretics. (notice Pipéracilline et tazobactam, Mises en garde et précautions)

  • PotassiumVitamines et minérauxMineure

    Les diurétiques de l'anse et les diurétiques thiazidiques augmentent la perte de potassium ; une supplémentation est parfois prescrite en même temps qu'eux. (NIH Office of Dietary Supplements, Potassium)

  • PrednisolonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • PrednisonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • Protriptylineantidépresseur tricycliqueMineure

    Protriptyline may block the antihypertensive effect of guanethidine or similarly acting compounds. (notice Protriptyline, Mises en garde)

  • TerbinafineantifongiqueMineure

    There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, phenytoins, thiazide diuretics, and calcium channel blockers. (notice Terbinafine, Interactions médicamenteuses)

  • TriamcinolonecorticoïdeMineure

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (notice Chlorothiazide, Interactions médicamenteuses)

  • ZincVitamines et minérauxMineure

    Les diurétiques thiazidiques augmentent la perte de zinc dans les urines en cas d'utilisation à long terme. (NIH Office of Dietary Supplements, Zinc)

Aucune interaction significative signalée (2)

  • Acide pamidroniquebisphosphonateAucune interaction

    Loop Diuretics Concomitant administration of a loop diuretic had no effect on the calcium-lowering action of pamidronate disodium. (notice Acide pamidronique, Interactions médicamenteuses)

  • Ropiniroleagoniste de la dopamineAucune interaction

    Commonly Administered Drugs: Population analysis showed that commonly administered drugs (e.g., selegiline, amantadine, tricyclic antidepressants, benzodiazepines, ibuprofen, thiazides, antihistamines, anticholinergics) did not affect the clearance of ropinirole. (notice Ropinirole, Interactions médicamenteuses)

Vérifiez Chlorothiazide avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.

Ouvrir dans le vérificateur

Ceci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.